NCT02172404View on ClinicalTrials.gov

HandiHaler® vs. Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

June 30, 2001

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DEVICE

Placebo capsule administered via the HandiHaler®

DEVICE

Ipratropium metered dose inhaler (MDI)

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY